Table 3.
Study type and location of decentralised clinical trials by study phase
| Phase I | Phase I/II | Phase II | Phase II/III | Phase III | Phase IV | ||
| n=13 (17.1%) | n=2 (2.6%) | n=21 (27.6%) | n=3 (3.9%) | n=10 (13.2%) | n=27 (35.5%) | ||
| Study type | Single-country trial | 12 | 2 | 18 | 2 | 6 | 21 |
| Single regional trial | 1 | 3 | 4 | ||||
| Multiregional trial | 1 | 4 | 2 | ||||
| Study location* | North America | 2 | 2 | ||||
| Canada | 1 | (1) | 3 (1) | ||||
| USA | 7 | 2 | 15 | 2 (1) | 3 (3) | 13 (2) | |
| Europe | 1 | 1 | 2 | ||||
| Belarus | (1) | ||||||
| Belgium | 1 (2) | ||||||
| Bulgaria | (1) | ||||||
| Denmark | (1) | (1) | |||||
| Finland | 1 | ||||||
| France | 1 (2) | 1 | |||||
| Germany | 1 (2) | 1 (1) | |||||
| Israel | (1) | ||||||
| Italy | (1) | ||||||
| Netherlands | 1 (2) | ||||||
| Poland | (1) | ||||||
| Rumania | (1) | ||||||
| Russian Federation | (2) | ||||||
| Spain | (1) | (1) | |||||
| Sweden | 2 | 1 | (1) | ||||
| Turkey | (1) | ||||||
| Ukraine | (1) | ||||||
| UK | 1 | 1 | (1) | 1 (1) | |||
| Asia-Pacific | |||||||
| Australia | 1 | 1 | (2) | (1) | |||
| India | (1) | ||||||
| Korea, Republic | (1) | 1 | |||||
| Japan | (1) | ||||||
| Taiwan | (1) | ||||||
*The number in parentheses indicates the number of multiregional studies.